SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is experiencing significant volatility and high short interest as investors weigh its aggressive growth narrative against broader market pressures and competitive dynamics. While the community remains polarized by the stock's recent price action, many long-term shareholders are actively accumulating shares on dips, betting that the companys distribution strength and international expansion will trigger a major reversal ahead of upcoming earnings.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global Inc. is experiencing heightened volatility and trading volume as investors react to renewed geopolitical tensions in the Strait of Hormuz, which threaten to disrupt critical global LNG supply routes. The community is actively debating the company's long-term valuation and capacity for record EBITDA growth against the backdrop of potential Middle East supply constraints and recent financing developments.

NextNav, Inc. engages in development of positioning, navigation, and timing solutions. Its products include NextNav Pinnacle, NextNav 3D, and NextNav TerraPoiNT. The company was founded by Ganesh Pattabiraman and Arun Raghupathy in May 2021 and is headquartered in Reston, VA.

NextNav Inc

NextNav is trending due to anticipation surrounding the FCC's potential approval of a Notice of Proposed Rulemaking (NPRM) for the company's 900 MHz spectrum band. The community is focused on recent capital strengthening and active spectrum rebanding efforts as key catalysts, while monitoring legislative developments and FCC meeting agendas for validation of the long-term thesis.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is seeing increased investor focus due to anticipation surrounding the FLAMINGO-01 Phase III clinical trial, with the community closely tracking potential catalysts like regulatory updates and upcoming data presentations. Discussion is centered on the company's efforts to expand trial eligibility and the broader strategic implications of its peptide vaccine platform within the oncology sector.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgical is facing a period of heightened market scrutiny as investors weigh solid quarterly performance and recurring revenue growth against concerns regarding slowing US procedure growth and intensifying competitive pressures in international markets. The community remains divided, with long-term bulls highlighting the company's strong operational moat and robotic surgery dominance, while more cautious participants are focused on the stock's recent volatility and whether its premium valuation remains justified amidst moderating expansion.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

REalloys Inc. is trending as investors digest news of its strategic partnership with the U.S. Army to develop domestic rare earth processing, alongside its official inclusion in the Russell 3000 index. While the community is split between bullish sentiment regarding the company's long-term role in U.S. supply chain independence and bearish accusations of it being a highly volatile, diluted, or fraudulent play, active discussion is dominated by debates over its massive short interest, potential for a squeeze, and its aggressive expansion into military and government-backed projects.

QXO, Inc. is a publicly traded distributor of roofing, waterproofing and complementary building products in the United States. It plans to become tech-enabled in the building products distribution industry and generate outsized value for shareholders. The company was founded on October 3, 2002, and is headquartered in Greenwich, CT.

QXO Inc.

QXO is facing significant selling pressure and heightened volatility as the market digests the recent TopBuild acquisition, with investors split between frustration over share dilution and confidence in Brad Jacobs' long-term consolidation strategy. While the community remains divided over the immediate price action and the impact of institutional selling, many are using the dip to accumulate shares, viewing the current weakness as a temporary mechanical hurdle in a multi-year growth story.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Investors are actively debating market volatility and the impact of geopolitical tensions, particularly as the community analyzes the potential for a tech sector correction despite recent stabilization attempts. Trading activity remains dominated by intense discussions around monthly option expiration dynamics, with many monitoring critical support levels and the sustainability of AI-driven capital expenditure.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing extreme volatility driven by a combination of retail-driven sentiment, massive options expiration activity, and algorithmic trading. The community remains deeply divided, with some investors viewing the price action as blatant market manipulation while others are actively buying the dip, banking on a long-term recovery rooted in AI infrastructure demand.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending due to heightened investor focus on the upcoming FDA advisory committee meeting and an ongoing patent lawsuit that has introduced significant volatility and legal uncertainty. Despite this, the community remains actively engaged in discussions regarding the strength of HOPE-3 trial data, the company's recent expansion of its San Diego manufacturing footprint, and expectations for a favorable regulatory path for its lead candidate, deramiocel.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Best Momentum Stocks to Buy for July 13th

SNDK, PTGX and LION made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 13th, 2026.

New Strong Buy Stocks for July 13th

FOX, LION, EDRY, PTGX and SPH have been added to the Zacks Rank #1 (Strong Buy) List on July 13th, 2026.

New Strong Buy Stocks for July 9th

PTGX, DHX, COOK, XYZ and ARLP have been added to the Zacks Rank #1 (Strong Buy) List on July 9, 2026.

Protagonist Therapeutics (PTGX) Surges 7.1%: Is This an Indication of Further Gains?

Protagonist Therapeutics (PTGX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Strength Seen in Agios Pharmaceuticals (AGIO): Can Its 17.7% Jump Turn into More Strength?

Agios Pharmaceuticals (AGIO) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

PTGX Stock Surges 64% in Six Months: What Is Driving the Rally?

Protagonist shares rise as rusfertide nears an FDA decision and Icotyde adds milestone payments, royalties and broader pipeline momentum.

J&J or AbbVie: Which Stock Deserves a Place in Your Portfolio Now?

JNJ and ABBV both offer solid long-term growth potential, but differences in diversification, pipeline strength and estimates may give one stock an edge.

J&J Stock Down 3% in 3 Months: Is the Dip a Buying Opportunity?

J&J's shares fall 3% in three months despite solid results and pipeline progress, raising questions about whether the pullback is a buying opportunity.

JNJ and AZN Face Patent Headwinds: Which Stock Looks Stronger Now?

J&J's diversified healthcare business and growth outlook help it stand out against AstraZeneca despite patent and legal challenges.

J&J Stock Gains Nearly 12% Year to Date: Buy, Sell or Hold Now?

JNJ is up nearly 12% YTD as strong oncology drug growth, MedTech demand and pipeline advances help offset Stelara patent-loss pressure.

Protagonist Therapeutics, Inc. a clinical-stage biopharmaceutical company, which engages in discovering and developing peptide-based therapeutic drugs to address unmet medical needs. Its product pipeline includes PTG-300, PTG-200, and PN-943. The company was founded by Mark L. Smythe on August 22, 2006 and is headquartered in Newark, CA.

Protagonist Therapeutics Inc

Wall Street Says Johnson And Johnson’s FDA-Approved Psoriasis Drug Should Create 'Significant Value’ For Protagonist Therapeutics

Equity

Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is pacing for a losing week as a semiconductor ($SMH) sell-off has dragged the market lower amid growing doubts about AI spending. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$2.14	--	--	N/A
Q1 '26	-$0.43	$0.05	111.54%	BEAT
Q4 '25	-$0.35	-$0.69	-97.86%	MISSED
Q3 '25	-$0.60	-$0.62	-3.11%	MISSED
Q2 '25	-$0.53	-$0.55	-4.10%	MISSED

Feed

News

Sentiment

Earnings

Fundamentals

Info

PTGXProtagonist Therapeutics Inc

Upcoming Earnings: Q2 '26

Historical Earnings

Latest PTGX News